Survey of Prostate Cancer in Accra, Ghana
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Prostate Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 19 recorded versions since 2002 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
19 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2020 — Jan 2021 [monthly]
Completed
-
May 2020 — Jun 2020 [monthly]
Completed
▶ Show 14 earlier versions
-
Apr 2020 — May 2020 [monthly]
Completed
-
Mar 2020 — Apr 2020 [monthly]
Completed
-
Jan 2020 — Mar 2020 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Oct 2019 — Nov 2019 [monthly]
Completed
-
May 2019 — Oct 2019 [monthly]
Completed
-
Mar 2019 — May 2019 [monthly]
Completed
-
Dec 2018 — Mar 2019 [monthly]
Completed
-
Sep 2018 — Dec 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- National Institute on Minority Health and Health Disparities (NIMHD)
For direct contact, visit the study record on ClinicalTrials.gov .